Advanced Solid Tumors Clinical Trials in Oklahoma City, Oklahoma

3 studies are recruiting for advanced solid tumors in Oklahoma City, Oklahoma right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

    This is a first-in-human, Phase I, open-label, multicenter, dose-escalation and dose expansion study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary anti-tumor activity of VVD-133214 monotherapy, and in combination with bevacizumab or pembrolizumab, in part…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Oklahoma University Health Sciences Center, Oklahoma City, Oklahoma
    Locations
    47 in total
    Run by
    Vividion Therapeutics, Inc.

    See if you can join NCT06004245 on ClinicalTrials.gov

  2. Phase 1/2 Study of PYX-201 in Combination With Pembrolizumab in Advanced Solid Tumors

    The primary objective of this study is to determine the recommended Phase 2 doses (RP2D(s)) and maximum tolerated dose (MTD) of PYX-201 in combination with pembrolizumab for participants with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Stephenson Cancer Center - University of Oklahoma, Oklahoma City, Oklahoma
    Locations
    22 in total
    Run by
    Pyxis Oncology, Inc

    See if you can join NCT06795412 on ClinicalTrials.gov

  3. A Clinical Study of YL205 in Patients With Advanced Solid Tumors

    This study is a multicenter, open-label, phase I/II study of YL205 in China to evaluate the safety, tolerability, PK characteristics and preliminary efficacy of YL205 in the following selected patients with advanced solid tumors.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Stephenson Cancer Center (Oklahoma), Oklahoma City, Oklahoma
    Locations
    43 in total
    Run by
    MediLink Therapeutics (Suzhou) Co., Ltd.

    See if you can join NCT06459973 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.